The University of Chicago Header Logo

Connection

Issam Awad to Female

Back to Details
This is a "connection" page, showing publications Issam Awad has written about Female.
Issam Awad
Connection Strength
1.474
Female
  1. Identifying features of prior hemorrhage in cerebral cavernous malformations on quantitative susceptibility maps: a machine learning pilot study. J Neurosurg. 2025 Dec 01; 143(6):1567-1574.
    View in: PubMed
    Score: 0.044
  2. Safety and efficacy of atorvastatin for rebleeding in cerebral cavernous malformations (AT CASH EPOC): a phase 1/2a, randomised placebo-controlled trial. Lancet Neurol. 2025 Apr; 24(4):295-304.
    View in: PubMed
    Score: 0.043
  3. Circulating molecules reflect imaging biomarkers of hemorrhage in cerebral cavernous malformations. J Cereb Blood Flow Metab. 2025 Jun; 45(6):1153-1165.
    View in: PubMed
    Score: 0.042
  4. COVID-19 in a Hemorrhagic Neurovascular Disease, Cerebral Cavernous Malformation. J Stroke Cerebrovasc Dis. 2021 Nov; 30(11):106101.
    View in: PubMed
    Score: 0.033
  5. Post-Trial Enhanced Deployment and Technical Performance with the MISTIE Procedure per Lessons Learned. J Stroke Cerebrovasc Dis. 2021 Sep; 30(9):105996.
    View in: PubMed
    Score: 0.033
  6. A Roadmap for Developing Plasma Diagnostic and Prognostic Biomarkers of Cerebral Cavernous Angioma With Symptomatic Hemorrhage (CASH). Neurosurgery. 2021 02 16; 88(3):686-697.
    View in: PubMed
    Score: 0.032
  7. Propranolol inhibits cavernous vascular malformations by ß1 adrenergic receptor antagonism in animal models. J Clin Invest. 2021 02 01; 131(3).
    View in: PubMed
    Score: 0.032
  8. Surgical Performance Determines Functional Outcome Benefit in the Minimally Invasive Surgery Plus Recombinant Tissue Plasminogen Activator for Intracerebral Hemorrhage Evacuation (MISTIE) Procedure. Neurosurgery. 2019 06 01; 84(6):1157-1168.
    View in: PubMed
    Score: 0.029
  9. Symptomatic Hemorrhagic Complications in Clot Lysis: Evaluation of Accelerated Resolution of Intraventricular Hemorrhage Phase III Clinical Trial (CLEAR III): A Posthoc Root-Cause Analysis. Neurosurgery. 2018 12 01; 83(6):1260-1268.
    View in: PubMed
    Score: 0.028
  10. Patients with cranial dural arteriovenous fistulas may benefit from expanded hypercoagulability and cancer screening. J Neurosurg. 2018 10; 129(4):954-960.
    View in: PubMed
    Score: 0.026
  11. Surgical Performance in Minimally Invasive Surgery Plus Recombinant Tissue Plasminogen Activator for Intracerebral Hemorrhage Evacuation Phase III Clinical Trial. Neurosurgery. 2017 Nov 01; 81(5):860-866.
    View in: PubMed
    Score: 0.026
  12. Plasma Biomarkers of Inflammation Reflect Seizures and Hemorrhagic Activity of Cerebral Cavernous Malformations. Transl Stroke Res. 2018 02; 9(1):34-43.
    View in: PubMed
    Score: 0.025
  13. Quantitative susceptibility mapping as a monitoring biomarker in cerebral cavernous malformations with recent hemorrhage. J Magn Reson Imaging. 2018 04; 47(4):1133-1138.
    View in: PubMed
    Score: 0.025
  14. RhoA Kinase Inhibition With Fasudil Versus Simvastatin in Murine Models of Cerebral Cavernous Malformations. Stroke. 2017 01; 48(1):187-194.
    View in: PubMed
    Score: 0.024
  15. Micro-computed tomography in murine models of cerebral cavernous malformations as a paradigm for brain disease. J Neurosci Methods. 2016 09 15; 271:14-24.
    View in: PubMed
    Score: 0.023
  16. B-Cell Depletion Reduces the Maturation of Cerebral Cavernous Malformations in Murine Models. J Neuroimmune Pharmacol. 2016 06; 11(2):369-77.
    View in: PubMed
    Score: 0.023
  17. Quantitative Susceptibility Mapping in Cerebral Cavernous Malformations: Clinical Correlations. AJNR Am J Neuroradiol. 2016 Jul; 37(7):1209-15.
    View in: PubMed
    Score: 0.023
  18. Peripheral plasma vitamin D and non-HDL cholesterol reflect the severity of cerebral cavernous malformation disease. Biomark Med. 2016; 10(3):255-64.
    View in: PubMed
    Score: 0.023
  19. Vascular permeability in cerebral cavernous malformations. J Cereb Blood Flow Metab. 2015 Oct; 35(10):1632-9.
    View in: PubMed
    Score: 0.022
  20. Immune complex formation and in situ B-cell clonal expansion in human cerebral cavernous malformations. J Neuroimmunol. 2014 Jul 15; 272(1-2):67-75.
    View in: PubMed
    Score: 0.020
  21. Dynamic permeability and quantitative susceptibility: related imaging biomarkers in cerebral cavernous malformations. Stroke. 2014 Feb; 45(2):598-601.
    View in: PubMed
    Score: 0.019
  22. Intensive care after elective craniotomy: "all politics is local". World Neurosurg. 2014 Jan; 81(1):64-5.
    View in: PubMed
    Score: 0.018
  23. Ventricular catheter location and the clearance of intraventricular hemorrhage. Neurosurgery. 2012 May; 70(5):1258-63; discussion 1263-4.
    View in: PubMed
    Score: 0.017
  24. A randomized trial of brief treatment of early- stage Hodgkin lymphoma: Is it effective? Hematol Oncol Stem Cell Ther. 2012; 5(1):36-41.
    View in: PubMed
    Score: 0.017
  25. Fenestration of supraclinoid internal carotid artery and associated aneurysm: embryogenesis, recognition, and management. World Neurosurg. 2011 Dec; 76(6):592.e1-5.
    View in: PubMed
    Score: 0.017
  26. A "pseudo-cavernoma" - an encapsulated hematoma of the choroid plexus. J Clin Neurosci. 2011 Jun; 18(6):846-8.
    View in: PubMed
    Score: 0.016
  27. Outcome predictors and spectrum of treatment eligibility with prospective protocolized management of intracerebral hemorrhage. Neurosurgery. 2009 Mar; 64(3):436-45; discussion 445-6.
    View in: PubMed
    Score: 0.014
  28. Advanced magnetic resonance imaging of cerebral cavernous malformations: part I. High-field imaging of excised human lesions. Neurosurgery. 2008 Oct; 63(4):782-9; discussion 789.
    View in: PubMed
    Score: 0.014
  29. Advanced magnetic resonance imaging of cerebral cavernous malformations: part II. Imaging of lesions in murine models. Neurosurgery. 2008 Oct; 63(4):790-7; discussion 797-8.
    View in: PubMed
    Score: 0.014
  30. Spectrum of genotype and clinical manifestations in cerebral cavernous malformations. Neurosurgery. 2006 Dec; 59(6):1278-84; discussion 1284-5.
    View in: PubMed
    Score: 0.012
  31. Intracerebral haemorrhage laterality and associations with mood and pain: a MISTIE III substudy. Stroke Vasc Neurol. 2025 Dec 23; 10(6):734-742.
    View in: PubMed
    Score: 0.011
  32. Impact of Minimally Invasive Surgery on Midline Shift and Outcomes in Large Supratentorial Spontaneous Intracerebral Hemorrhage: Post Hoc Analysis of MISTIE III. Neurocrit Care. 2026 Feb; 44(1):261-272.
    View in: PubMed
    Score: 0.011
  33. Association of Quality of Life Domains and Clinical Symptoms in Patients With Familial Cerebral Cavernous Malformation. J Am Heart Assoc. 2025 Sep 02; 14(17):e035926.
    View in: PubMed
    Score: 0.011
  34. Safety, Tolerability, and Pharmacokinetics of NRL-1049, a Rho-Associated Kinase Inhibitor, in Healthy Volunteers: A Phase 1, First-in-Human, Single-Ascending Dose, Randomized, Placebo-Controlled Trial. CNS Drugs. 2025 Sep; 39(9):865-877.
    View in: PubMed
    Score: 0.011
  35. Variations in structural protein expression and endothelial cell proliferation in relation to clinical manifestations of cerebral cavernous malformations. Neurosurgery. 2005 Feb; 56(2):343-54.
    View in: PubMed
    Score: 0.011
  36. Does stereotactic thrombolysis with alteplase for intracerebral haemorrhage alter intraventricular haematoma volume? A secondary analysis of the MISTIE-III trial. J Neurol Neurosurg Psychiatry. 2024 Sep 17; 95(10):892-898.
    View in: PubMed
    Score: 0.010
  37. Cerebral small vessel disease modifies outcomes after minimally invasive surgery for intracerebral haemorrhage. Stroke Vasc Neurol. 2024 08 27; 9(4):446-456.
    View in: PubMed
    Score: 0.010
  38. Mild Hypoxia Accelerates Cerebral Cavernous Malformation Disease Through CX3CR1-CX3CL1 Signaling. Arterioscler Thromb Vasc Biol. 2024 06; 44(6):1246-1264.
    View in: PubMed
    Score: 0.010
  39. Pathologic features of brain hemorrhage after radiation treatment: case series with somatic mutation analysis. J Stroke Cerebrovasc Dis. 2024 Jul; 33(7):107699.
    View in: PubMed
    Score: 0.010
  40. Association Between Hematoma Volume and Risk of Subsequent Ischemic Stroke: A MISTIE III and ATACH-2 Analysis. Stroke. 2024 03; 55(3):541-547.
    View in: PubMed
    Score: 0.010
  41. Mechanistic Evaluation of Diffusion Weighted Hyperintense Lesions After Large Spontaneous Intracerebral Hemorrhage: A Subgroup Analysis of MISTIE III. Neurocrit Care. 2024 Jun; 40(3):1140-1150.
    View in: PubMed
    Score: 0.010
  42. Catheter Tract Hemorrhages and Intracerebral Hemorrhage Outcomes in the Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Trial. Neurosurgery. 2024 02 01; 94(2):334-339.
    View in: PubMed
    Score: 0.010
  43. Underlying intracranial atherosclerotic disease is associated with worse outcomes in acute large vessel occlusion undergoing endovascular thrombectomy. J Stroke Cerebrovasc Dis. 2023 Aug; 32(8):107227.
    View in: PubMed
    Score: 0.009
  44. Differential gene expression in human cerebrovascular malformations. Neurosurgery. 2003 Feb; 52(2):465-77; discussion 477-8.
    View in: PubMed
    Score: 0.009
  45. One-Year Outcome Trajectories and Factors Associated with Functional Recovery Among Survivors of Intracerebral and Intraventricular Hemorrhage With Initial Severe Disability. JAMA Neurol. 2022 09 01; 79(9):856-868.
    View in: PubMed
    Score: 0.009
  46. Intraventricular Hemorrhage Expansion in the CLEAR III Trial: A Post Hoc Exploratory Analysis. Stroke. 2022 06; 53(6):1847-1853.
    View in: PubMed
    Score: 0.009
  47. Further study of CD31 protein and messenger ribonucleic acid expression in human cerebral vascular malformations. Neurosurgery. 2002 Jan; 50(1):110-5; discussion 115-6.
    View in: PubMed
    Score: 0.009
  48. Association Between Intraventricular Alteplase Use and Parenchymal Hematoma Volume in Patients With Spontaneous Intracerebral Hemorrhage and Intraventricular Hemorrhage. JAMA Netw Open. 2021 12 01; 4(12):e2135773.
    View in: PubMed
    Score: 0.008
  49. Perfusion and Permeability MRI Predicts Future Cavernous Angioma Hemorrhage and Growth. J Magn Reson Imaging. 2022 05; 55(5):1440-1449.
    View in: PubMed
    Score: 0.008
  50. Baseline Characteristics of Patients With Cavernous Angiomas With Symptomatic Hemorrhage in Multisite Trial Readiness Project. Stroke. 2021 12; 52(12):3829-3838.
    View in: PubMed
    Score: 0.008
  51. Post-Stroke Depression in Patients with Large Spontaneous Intracerebral Hemorrhage. J Stroke Cerebrovasc Dis. 2021 Nov; 30(11):106082.
    View in: PubMed
    Score: 0.008
  52. Vascular smooth muscle cell differentiation in human cerebral vascular malformations. Neurosurgery. 2001 Sep; 49(3):671-9; discussion 679-80.
    View in: PubMed
    Score: 0.008
  53. CSF and serum inflammatory response and association with outcomes in spontaneous intracerebral hemorrhage with intraventricular extension: an analysis of the CLEAR-III Trial. J Neuroinflammation. 2021 Aug 21; 18(1):179.
    View in: PubMed
    Score: 0.008
  54. Perfusion and permeability as diagnostic biomarkers of cavernous angioma with symptomatic hemorrhage. J Cereb Blood Flow Metab. 2021 11; 41(11):2944-2956.
    View in: PubMed
    Score: 0.008
  55. Leukocyte dynamics after intracerebral hemorrhage in a living patient reveal rapid adaptations to tissue milieu. JCI Insight. 2021 03 22; 6(6).
    View in: PubMed
    Score: 0.008
  56. Longitudinal transcriptomics define the stages of myeloid activation in the living human brain after intracerebral hemorrhage. Sci Immunol. 2021 02 19; 6(56).
    View in: PubMed
    Score: 0.008
  57. Expression of endothelial cell angiogenesis receptors in human cerebrovascular malformations. Neurosurgery. 2001 Feb; 48(2):359-67; discussion 367-8.
    View in: PubMed
    Score: 0.008
  58. Temporal Evolution and Outcomes of Non-Traumatic Intracerebral Hemorrhage in Hospitalized Patients. J Stroke Cerebrovasc Dis. 2021 Mar; 30(3):105584.
    View in: PubMed
    Score: 0.008
  59. Impact of Intracranial Pressure Monitor-Guided Therapy on Neurologic Outcome After Spontaneous Nontraumatic Intracranial Hemorrhage. J Stroke Cerebrovasc Dis. 2021 Mar; 30(3):105540.
    View in: PubMed
    Score: 0.008
  60. A Pooled Analysis of Diffusion-Weighted Imaging Lesions in Patients With Acute Intracerebral Hemorrhage. JAMA Neurol. 2020 Nov 01; 77(11):1390-1397.
    View in: PubMed
    Score: 0.008
  61. Cerebral cavernous malformations are driven by ADAMTS5 proteolysis of versican. J Exp Med. 2020 10 05; 217(10).
    View in: PubMed
    Score: 0.008
  62. Intraoperative endovascular treatment as an adjunct to microsurgical clipping of paraclinoid aneurysms. J Neurosurg. 2000 Oct; 93(4):554-60.
    View in: PubMed
    Score: 0.008
  63. Impact of Guglielmi detachable coils on outcomes of patients with intracranial aneurysms treated by a multidisciplinary team at a single institution. J Neurosurg. 2000 Oct; 93(4):569-80.
    View in: PubMed
    Score: 0.008
  64. Permissive microbiome characterizes human subjects with a neurovascular disease cavernous angioma. Nat Commun. 2020 05 27; 11(1):2659.
    View in: PubMed
    Score: 0.008
  65. Antibodies in cerebral cavernous malformations react with cytoskeleton autoantigens in the lesional milieu. J Autoimmun. 2020 09; 113:102469.
    View in: PubMed
    Score: 0.008
  66. Subclinical imaging changes in cerebral cavernous angiomas during prospective surveillance. J Neurosurg. 2021 03 01; 134(3):1147-1154.
    View in: PubMed
    Score: 0.008
  67. Carotid endarterectomy prevention strategies and complications management. Neurosurg Clin N Am. 2000 Apr; 11(2):351-64.
    View in: PubMed
    Score: 0.008
  68. Stereotactic computed tomographic-guided aspiration and thrombolysis of intracerebral hematoma : protocol and preliminary experience. Stroke. 2000 Apr; 31(4):834-40.
    View in: PubMed
    Score: 0.008
  69. Stereotactic laser interstitial thermal therapy for epilepsy associated with solitary and multiple cerebral cavernous malformations. Neurosurg Focus. 2020 04 01; 48(4):E12.
    View in: PubMed
    Score: 0.008
  70. Symptomatic Brain Hemorrhages from Cavernous Angioma After Botulinum Toxin Injections, a Role of TLR/MEKK3 Mechanism? Case Report and Review of the Literature. World Neurosurg. 2020 Apr; 136:7-11.
    View in: PubMed
    Score: 0.007
  71. Toward more rational prediction of outcome in patients with high-grade subarachnoid hemorrhage. Neurosurgery. 2000 Jan; 46(1):28-35; discussion 35-6.
    View in: PubMed
    Score: 0.007
  72. Atorvastatin Treatment of Cavernous Angiomas with Symptomatic Hemorrhage Exploratory Proof of Concept (AT CASH EPOC) Trial. Neurosurgery. 2019 12 01; 85(6):843-853.
    View in: PubMed
    Score: 0.007
  73. Intracranial Hypertension and Cerebral Perfusion Pressure Insults in Adult Hypertensive Intraventricular Hemorrhage: Occurrence and Associations With Outcome. Crit Care Med. 2019 08; 47(8):1125-1134.
    View in: PubMed
    Score: 0.007
  74. Biomarkers of cavernous angioma with symptomatic hemorrhage. JCI Insight. 2019 06 20; 4(12).
    View in: PubMed
    Score: 0.007
  75. A randomized 500-subject open-label phase 3 clinical trial of minimally invasive surgery plus alteplase in intracerebral hemorrhage evacuation (MISTIE III). Int J Stroke. 2019 07; 14(5):548-554.
    View in: PubMed
    Score: 0.007
  76. Efficacy and safety of minimally invasive surgery with thrombolysis in intracerebral haemorrhage evacuation (MISTIE III): a randomised, controlled, open-label, blinded endpoint phase 3 trial. Lancet. 2019 Mar 09; 393(10175):1021-1032.
    View in: PubMed
    Score: 0.007
  77. Spontaneous angiographic obliteration of cerebral arteriovenous malformations. Neurosurgery. 1999 Feb; 44(2):280-7; discussion 287-8.
    View in: PubMed
    Score: 0.007
  78. A comparison of the clinical profile of cavernous malformations with and without associated venous malformations. Neurosurgery. 1999 Jan; 44(1):41-6; discussion 46-7.
    View in: PubMed
    Score: 0.007
  79. Influence of Bleeding Pattern on Ischemic Lesions After Spontaneous Hypertensive Intracerebral Hemorrhage with Intraventricular Hemorrhage. Neurocrit Care. 2018 10; 29(2):180-188.
    View in: PubMed
    Score: 0.007
  80. Occipital lobe vascular malformations: prevalence of visual field deficits and prognosis after therapeutic intervention. Neurosurgery. 1998 Sep; 43(3):415-21; discussion 421-3.
    View in: PubMed
    Score: 0.007
  81. Failure of the hypotensive provocative test during temporary balloon test occlusion of the internal carotid artery to predict delayed hemodynamic ischemia after therapeutic carotid occlusion. Surg Neurol. 1998 Aug; 50(2):147-55; discussion 155-6.
    View in: PubMed
    Score: 0.007
  82. The Incidence of Catheter Tract Hemorrhage and Catheter Placement Accuracy in the CLEAR III Trial. Neurocrit Care. 2018 08; 29(1):23-32.
    View in: PubMed
    Score: 0.007
  83. Plasma Biomarkers of Inflammation and Angiogenesis Predict Cerebral Cavernous Malformation Symptomatic Hemorrhage or Lesional Growth. Circ Res. 2018 06 08; 122(12):1716-1721.
    View in: PubMed
    Score: 0.007
  84. CSF inflammatory response after intraventricular hemorrhage. Neurology. 2017 Oct 10; 89(15):1553-1560.
    View in: PubMed
    Score: 0.006
  85. Permanent CSF shunting after intraventricular hemorrhage in the CLEAR III trial. Neurology. 2017 Jul 25; 89(4):355-362.
    View in: PubMed
    Score: 0.006
  86. Cerebral vascular malformations adjacent to sensorimotor and visual cortex. Functional magnetic resonance imaging studies before and after therapeutic intervention. Stroke. 1997 Jun; 28(6):1130-7.
    View in: PubMed
    Score: 0.006
  87. Endothelial TLR4 and the microbiome drive cerebral cavernous malformations. Nature. 2017 05 18; 545(7654):305-310.
    View in: PubMed
    Score: 0.006
  88. Demographic Risk Factors for Vascular Lesions as Etiology of Intraventricular Hemorrhage in Prospectively Screened Cases. Cerebrovasc Dis. 2017; 43(5-6):223-230.
    View in: PubMed
    Score: 0.006
  89. Thrombolytic removal of intraventricular haemorrhage in treatment of severe stroke: results of the randomised, multicentre, multiregion, placebo-controlled CLEAR III trial. Lancet. 2017 02 11; 389(10069):603-611.
    View in: PubMed
    Score: 0.006
  90. Safety and efficacy of minimally invasive surgery plus alteplase in intracerebral haemorrhage evacuation (MISTIE): a randomised, controlled, open-label, phase 2 trial. Lancet Neurol. 2016 Nov; 15(12):1228-1237.
    View in: PubMed
    Score: 0.006
  91. Genetic heterogeneity of inherited cerebral cavernous malformation. Neurosurgery. 1996 Jun; 38(6):1265-71.
    View in: PubMed
    Score: 0.006
  92. Giant aneurysms of the anterior circle of Willis: management outcome of open microsurgical treatment. Surg Neurol. 1996 May; 45(5):409-20; discussion 420-1.
    View in: PubMed
    Score: 0.006
  93. Cerebral cavernous malformations arise from endothelial gain of MEKK3-KLF2/4 signalling. Nature. 2016 Apr 07; 532(7597):122-6.
    View in: PubMed
    Score: 0.006
  94. Intracranial cavernous malformations: lesion behavior and management strategies. Neurosurgery. 1995 Oct; 37(4):591-605.
    View in: PubMed
    Score: 0.006
  95. Intracarotid amobarbital procedure as a predictor of material-specific memory change after anterior temporal lobectomy. Epilepsia. 1995 Sep; 36(9):857-65.
    View in: PubMed
    Score: 0.006
  96. Mapping a gene causing cerebral cavernous malformation to 7q11.2-q21. Proc Natl Acad Sci U S A. 1995 Jul 03; 92(14):6620-4.
    View in: PubMed
    Score: 0.005
  97. Bleeding and infection with external ventricular drainage: a systematic review in comparison with adjudicated adverse events in the ongoing Clot Lysis Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III (CLEAR-III IHV) trial. Neurosurgery. 2015 Mar; 76(3):291-300; discussion 301.
    View in: PubMed
    Score: 0.005
  98. Determinants of external ventricular drain placement and associated outcomes in patients with spontaneous intraventricular hemorrhage. Neurocrit Care. 2014 Dec; 21(3):426-34.
    View in: PubMed
    Score: 0.005
  99. Evaluation of iron content in human cerebral cavernous malformation using quantitative susceptibility mapping. Invest Radiol. 2014 Jul; 49(7):498-504.
    View in: PubMed
    Score: 0.005
  100. Guidelines for the prevention of stroke in women: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2014 May; 45(5):1545-88.
    View in: PubMed
    Score: 0.005
  101. Radiosurgery and venous malformations. J Neurosurg. 1994 Jan; 80(1):171-3; author reply 174-5.
    View in: PubMed
    Score: 0.005
  102. Pathogenesis of subcortical hyperintense lesions on magnetic resonance imaging of the brain. Observations in patients undergoing controlled therapeutic internal carotid artery occlusion. Stroke. 1993 Sep; 24(9):1339-46.
    View in: PubMed
    Score: 0.005
  103. A multicenter, randomized, double-blinded, placebo-controlled phase III study of Clot Lysis Evaluation of Accelerated Resolution of Intraventricular Hemorrhage (CLEAR III). Int J Stroke. 2014 Jun; 9(4):536-42.
    View in: PubMed
    Score: 0.005
  104. Mixed vascular malformations of the brain: clinical and pathogenetic considerations. Neurosurgery. 1993 Aug; 33(2):179-88; discussion 188.
    View in: PubMed
    Score: 0.005
  105. Giant aneurysms of the proximal anterior cerebral artery: report of three cases. Neurosurgery. 1993 Jul; 33(1):120-4; discussion 124-5.
    View in: PubMed
    Score: 0.005
  106. Minimally invasive surgery plus recombinant tissue-type plasminogen activator for intracerebral hemorrhage evacuation decreases perihematomal edema. Stroke. 2013 Mar; 44(3):627-34.
    View in: PubMed
    Score: 0.005
  107. The Modified Graeb Score: an enhanced tool for intraventricular hemorrhage measurement and prediction of functional outcome. Stroke. 2013 Mar; 44(3):635-41.
    View in: PubMed
    Score: 0.005
  108. Intensive care management of acute hemorrhagic leukoencephalitis with favorable neurologic outcome. Cleve Clin J Med. 1992 Sep-Oct; 59(5):549-52.
    View in: PubMed
    Score: 0.004
  109. Further observations on the pathology of subcortical lesions identified on magnetic resonance imaging. Arch Neurol. 1992 Jul; 49(7):747-52.
    View in: PubMed
    Score: 0.004
  110. Drainage efficiency with dual versus single catheters in severe intraventricular hemorrhage. Neurocrit Care. 2012 Jun; 16(3):399-405.
    View in: PubMed
    Score: 0.004
  111. Occurrence and impact of intracranial pressure elevation during treatment of severe intraventricular hemorrhage. Crit Care Med. 2012 May; 40(5):1601-8.
    View in: PubMed
    Score: 0.004
  112. Brainstem cavernous malformations: 1390 surgical cases from the literature. World Neurosurg. 2013 Jul-Aug; 80(1-2):89-93.
    View in: PubMed
    Score: 0.004
  113. Resolution of intraventricular hemorrhage varies by ventricular region and dose of intraventricular thrombolytic: the Clot Lysis: Evaluating Accelerated Resolution of IVH (CLEAR IVH) program. Stroke. 2012 Jun; 43(6):1666-8.
    View in: PubMed
    Score: 0.004
  114. A new class of electrodes of 'intermediate invasiveness': preliminary experience with epidural pegs and foramen ovale electrodes in the mapping of seizure foci. Neurol Res. 1991 Sep; 13(3):177-83.
    View in: PubMed
    Score: 0.004
  115. Low-dose recombinant tissue-type plasminogen activator enhances clot resolution in brain hemorrhage: the intraventricular hemorrhage thrombolysis trial. Stroke. 2011 Nov; 42(11):3009-16.
    View in: PubMed
    Score: 0.004
  116. A founder mutation in the Ashkenazi Jewish population affecting messenger RNA splicing of the CCM2 gene causes cerebral cavernous malformations. Genet Med. 2011 Jul; 13(7):662-6.
    View in: PubMed
    Score: 0.004
  117. Second operation after the failure of previous resection for epilepsy. Neurosurgery. 1991 Apr; 28(4):510-8.
    View in: PubMed
    Score: 0.004
  118. Intractable epilepsy and structural lesions of the brain: mapping, resection strategies, and seizure outcome. Epilepsia. 1991 Mar-Apr; 32(2):179-86.
    View in: PubMed
    Score: 0.004
  119. Magnetic resonance imaging evaluation of cerebral cavernous malformations with susceptibility-weighted imaging. Neurosurgery. 2011 Mar; 68(3):641-7; discussion 647-8.
    View in: PubMed
    Score: 0.004
  120. Intraventricular hemorrhage secondary to intranidal aneurysm rupture-successful management by arteriovenous malformation embolization followed by intraventricular tissue plasminogen activator: case report. Neurosurgery. 2011 Feb; 68(2):E581-6; discussion E586.
    View in: PubMed
    Score: 0.004
  121. Intracranial dural arteriovenous malformations: factors predisposing to an aggressive neurological course. J Neurosurg. 1990 Jun; 72(6):839-50.
    View in: PubMed
    Score: 0.004
  122. Alcohol histories in hospital: does the age and sex of the patient make a difference? Br J Addict. 1990 Jan; 85(1):149-50.
    View in: PubMed
    Score: 0.004
  123. Internal carotid artery occlusion for cavernous segment aneurysm. Neurosurgery. 1989 Sep; 25(3):398-404.
    View in: PubMed
    Score: 0.004
  124. Cerebral cavernous malformations: somatic mutations in vascular endothelial cells. Neurosurgery. 2009 Jul; 65(1):138-44; discussion 144-5.
    View in: PubMed
    Score: 0.004
  125. Intracranial meningiomas in the aged: surgical outcome in the era of computed tomography. Neurosurgery. 1989 Apr; 24(4):557-60.
    View in: PubMed
    Score: 0.004
  126. Genomics of human intracranial aneurysm wall. Stroke. 2009 Apr; 40(4):1252-61.
    View in: PubMed
    Score: 0.003
  127. Effect of local anaesthetic volume (20 vs 5 ml) on the efficacy and respiratory consequences of ultrasound-guided interscalene brachial plexus block. Br J Anaesth. 2008 Oct; 101(4):549-56.
    View in: PubMed
    Score: 0.003
  128. Preliminary report of the clot lysis evaluating accelerated resolution of intraventricular hemorrhage (CLEAR-IVH) clinical trial. Acta Neurochir Suppl. 2008; 105:217-20.
    View in: PubMed
    Score: 0.003
  129. Clinical vasospasm after subarachnoid hemorrhage: response to hypervolemic hemodilution and arterial hypertension. Stroke. 1987 Mar-Apr; 18(2):365-72.
    View in: PubMed
    Score: 0.003
  130. Incidental lesions noted on magnetic resonance imaging of the brain: prevalence and clinical significance in various age groups. Neurosurgery. 1987 Feb; 20(2):222-7.
    View in: PubMed
    Score: 0.003
  131. Incidental subcortical lesions identified on magnetic resonance imaging in the elderly. II. Postmortem pathological correlations. Stroke. 1986 Nov-Dec; 17(6):1090-7.
    View in: PubMed
    Score: 0.003
  132. Current updates in perioperative management of intracerebral hemorrhage. Neurol Clin. 2006 Nov; 24(4):745-64.
    View in: PubMed
    Score: 0.003
  133. Extracranial-intracranial bypass surgery: a critical analysis in light of the International Cooperative Study. Neurosurgery. 1986 Oct; 19(4):655-64.
    View in: PubMed
    Score: 0.003
  134. Retrograde suction decompression of giant paraclinoid aneurysms using a No. 7 French balloon-containing guide catheter. Technical note. J Neurosurg. 2006 Sep; 105(3):479-81.
    View in: PubMed
    Score: 0.003
  135. Leptomeningeal metastasis from supratentorial malignant gliomas. Neurosurgery. 1986 Aug; 19(2):247-51.
    View in: PubMed
    Score: 0.003
  136. [Etiologic spectrum of intracerebral hemorrhage in young patients]. Neurochirurgie. 2006 Jun; 52(2-3 Pt 1):105-9.
    View in: PubMed
    Score: 0.003
  137. Focal parenchymal lesions in transient ischemic attacks: correlation of computed tomography and magnetic resonance imaging. Stroke. 1986 May-Jun; 17(3):399-403.
    View in: PubMed
    Score: 0.003
  138. Ruptured superior cerebellar artery aneurysm in a child with bilateral fibromuscular hyperplasia of the renal arteries: case report and review of the literature. J Neurosurg. 2005 Apr; 102(3 Suppl):338-41.
    View in: PubMed
    Score: 0.003
  139. Neuroendovascular interventions for intracranial posterior circulation disease via the transradial approach: technical case report. Neurosurgery. 2005 Mar; 56(3):E626; discussion E626.
    View in: PubMed
    Score: 0.003
  140. Changes in intracranial stenotic lesions after extracranial-intracranial bypass surgery. J Neurosurg. 1984 Apr; 60(4):771-6.
    View in: PubMed
    Score: 0.002
  141. Coronary risk evaluation in patients with transient ischemic attack and ischemic stroke: a scientific statement for healthcare professionals from the Stroke Council and the Council on Clinical Cardiology of the American Heart Association/American Stroke Association. Circulation. 2003 Sep 09; 108(10):1278-90.
    View in: PubMed
    Score: 0.002
  142. Correlation of clinical and angiographic findings in brain ischemia with regional cerebral blood flow measured by the xenon inhalation technique. Neurosurgery. 1982 Jul; 11(1 Pt 1):1-5.
    View in: PubMed
    Score: 0.002
  143. Traumatic postsurgical aneurysm of the intracavernous carotid artery: a delayed presentation. Surg Neurol. 1982 Jul; 18(1):54-7.
    View in: PubMed
    Score: 0.002
  144. AHA Scientific Statement: Recommendations for the management of intracranial arteriovenous malformations: a statement for healthcare professionals from a special writing group of the Stroke Council, American Stroke Association. Stroke. 2001 Jun; 32(6):1458-71.
    View in: PubMed
    Score: 0.002
  145. A quality-of-life instrument for young hemorrhagic stroke patients. Stroke. 2001 Mar; 32(3):687-95.
    View in: PubMed
    Score: 0.002
  146. Case problems conference: Cushing's disease and parasellar aneurysm. Neurosurgery. 2000 Dec; 47(6):1420-9.
    View in: PubMed
    Score: 0.002
  147. Case problems conference: thoracic spinal cord hernia. Neurosurgery. 2000 Jun; 46(6):1408-15.
    View in: PubMed
    Score: 0.002
  148. Ultrastructural pathological features of cerebrovascular malformations: a preliminary report. Neurosurgery. 2000 Jun; 46(6):1454-9.
    View in: PubMed
    Score: 0.002
  149. Parenchymal perianeurysmal cystic changes in the brain: report of five cases. Radiology. 2000 Apr; 215(1):229-33.
    View in: PubMed
    Score: 0.002
  150. Neonatal galenic arteriovenous malformation. Neurosurgery. 1999 Apr; 44(4):847-54.
    View in: PubMed
    Score: 0.002
  151. Multilocus linkage identifies two new loci for a mendelian form of stroke, cerebral cavernous malformation, at 7p15-13 and 3q25.2-27. Hum Mol Genet. 1998 Nov; 7(12):1851-8.
    View in: PubMed
    Score: 0.002
  152. Creutzfeldt-Jakob disease in the elderly. Postgrad Med J. 1997 Sep; 73(863):557-9.
    View in: PubMed
    Score: 0.002
  153. Exceptional multiplicity of cerebral arteriovenous malformations associated with hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu syndrome). AJNR Am J Neuroradiol. 1996 Oct; 17(9):1733-42.
    View in: PubMed
    Score: 0.001
  154. Misdiagnosis of symptomatic cerebral aneurysm. Prevalence and correlation with outcome at four institutions. Stroke. 1996 Sep; 27(9):1558-63.
    View in: PubMed
    Score: 0.001
  155. Expression of angiogenesis factors and selected vascular wall matrix proteins in intracranial saccular aneurysms. Neurosurgery. 1996 Sep; 39(3):537-45; discussion 545-7.
    View in: PubMed
    Score: 0.001
  156. Expression of angiogenic factors and structural proteins in central nervous system vascular malformations. Neurosurgery. 1996 May; 38(5):915-24; discussion 924-5.
    View in: PubMed
    Score: 0.001
  157. A founder mutation as a cause of cerebral cavernous malformation in Hispanic Americans. N Engl J Med. 1996 Apr 11; 334(15):946-51.
    View in: PubMed
    Score: 0.001
  158. Expression of basement membrane and endothelial cell adhesion molecules in vascular malformations of the brain: preliminary observations and working hypothesis. Neurol Res. 1995 Feb; 17(1):49-58.
    View in: PubMed
    Score: 0.001
  159. Functional anatomy of the human supplementary sensorimotor area: results of extraoperative electrical stimulation. Electroencephalogr Clin Neurophysiol. 1994 Sep; 91(3):179-93.
    View in: PubMed
    Score: 0.001
  160. Occult intracranial aneurysms in polycystic kidney disease: screening with MR angiography. Radiology. 1994 Apr; 191(1):33-9.
    View in: PubMed
    Score: 0.001
  161. Pathological heterogeneity of angiographically occult vascular malformations of the brain. Neurosurgery. 1993 Oct; 33(4):547-54; discussion 554-5.
    View in: PubMed
    Score: 0.001
  162. Comparison and spacial correlation of interictal HMPAO-SPECT and FDG-PET in intractable temporal lobe epilepsy. Neurol Res. 1993 Jun; 15(3):160-8.
    View in: PubMed
    Score: 0.001
  163. Factors predisposing to clinical disability in patients with cavernous malformations of the brain. Neurosurgery. 1993 May; 32(5):730-5; discussion 735-6.
    View in: PubMed
    Score: 0.001
  164. Differences of in vitro electrophysiology of hippocampal neurons from epileptic patients with mesiotemporal sclerosis versus structural lesions. Epilepsia. 1992 Jul-Aug; 33(4):601-9.
    View in: PubMed
    Score: 0.001
  165. Natural history of recurrent seizures after resective surgery for epilepsy. Epilepsia. 1991 Nov-Dec; 32(6):851-6.
    View in: PubMed
    Score: 0.001
  166. Intracarotid amobarbital procedure: I. Prediction of decreased modality-specific memory scores after temporal lobectomy. Epilepsia. 1991 Nov-Dec; 32(6):857-64.
    View in: PubMed
    Score: 0.001
  167. Natural history of the cavernous angioma. J Neurosurg. 1991 Nov; 75(5):709-14.
    View in: PubMed
    Score: 0.001
  168. Sclerosing vasculopathy of the central nervous system in nonelderly demented patients. Arch Neurol. 1991 Jun; 48(6):631-6.
    View in: PubMed
    Score: 0.001
  169. Symptomatic Chiari malformation in adults: a new classification based on magnetic resonance imaging with clinical and prognostic significance. Neurosurgery. 1991 May; 28(5):639-45.
    View in: PubMed
    Score: 0.001
  170. Surgical management of syringomyelia: a five year experience in the era of magnetic resonance imaging. Neurol Res. 1991 Mar; 13(1):3-9.
    View in: PubMed
    Score: 0.001
  171. Delayed facial nerve palsy after temporal lobectomy for epilepsy: report of four cases and discussion of possible mechanisms. Neurosurgery. 1991 Mar; 28(3):453-6.
    View in: PubMed
    Score: 0.001
  172. Intractable complex partial seizures associated with occult temporal lobe encephalocele and meningoangiomatosis: a case report. Surg Neurol. 1990 Nov; 34(5):318-22.
    View in: PubMed
    Score: 0.001
  173. Vascular pressures and cortical blood flow in cavernous angioma of the brain. J Neurosurg. 1990 Oct; 73(4):555-9.
    View in: PubMed
    Score: 0.001
  174. Intracranial hypertension associated with unruptured cerebral arteriovenous malformations. Ann Neurol. 1990 May; 27(5):474-9.
    View in: PubMed
    Score: 0.001
  175. Proton magnetic resonance imaging in ischemic cerebrovascular disease. Ann Neurol. 1986 Oct; 20(4):502-7.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.